Overview

Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.
Phase:
Phase 3
Details
Lead Sponsor:
Alimera Sciences
Treatments:
Fluocinolone Acetonide